A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC
- Status
- RECRUITING
- Phase
- N/A
NearWave Optical Molecular Monitoring
- Status
- RECRUITING
- Phase
- NA
Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
- Status
- RECRUITING
- Phase
- N/A
Pyrotinib in HER2-positive Early Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
- Status
- RECRUITING
- Phase
- N/A
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
- Status
- RECRUITING
- Phase
- N/A
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- N/A
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TME Alteration in HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Status
- RECRUITING
- Phase
- PHASE2
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2